Molecular endotypes in musculoskeletal disorders: a systematic review

Ming Liu1, Jingyi Huang1, Ali Mobasheri2,3,4,5

  • 1Human Genetics & Genomics, Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Canada.

Abstract

Insights

This review summarizes molecular endotypes in musculoskeletal (MSK) disorders, finding early-stage research. More studies are needed to develop personalized therapies for conditions like osteoarthritis and rheumatoid arthritis.

Area of Science:

  • Rheumatology and Immunology
  • Genomics and Molecular Biology
  • Translational Medicine

Background:

  • Musculoskeletal (MSK) disorders exhibit significant heterogeneity with diverse underlying molecular mechanisms, known as endotypes.
  • Understanding these molecular endotypes is crucial for advancing diagnosis and treatment of MSK conditions.

Purpose of the Study:

  • To systematically review and synthesize current knowledge on molecular endotypes across various MSK disorders.
  • To identify research gaps and inform future directions in MSK endotype investigation.

Main Methods:

  • A comprehensive systematic review adhering to PRISMA guidelines was conducted.
  • Searches across five major databases (PubMed, Web of Science, Scopus, Ovid Medline, Embase) were performed for studies published before September 1st, 2024.
  • Inclusion criteria focused on peer-reviewed original research of adult-onset human MSK disorders using human specimens, with manual citation screening.

Main Results:

  • Out of 44,660 records, 34 studies were included, predominantly focusing on osteoarthritis (OA) and rheumatoid arthritis (RA).
  • Consistent findings in OA revealed high- and low-inflammation clusters, and in other MSK conditions, high- and low-pain clusters.
  • RA studies identified distinct inflammatory profiles, treatment responses, and even distinct gut microbiota patterns linked to treatment outcomes.

Conclusions:

  • Research into MSK endotypes is currently in its nascent stages.
  • Further dedicated endotype studies are essential for optimizing clinical trial design.
  • Advancing endotype research will facilitate the development of personalized therapeutic strategies for MSK disorders.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...